Stocktoria

BRISTOL MYERS SQUIBB CO BMY

NYSE · stock · Pharmaceutical Preparations · website · IPO 1980-03-17 · LEI

BRISTOL MYERS SQUIBB CO statistics & valuation

Market cap$117.5B
P / E16.7×
P / S2.4×
P / B6.3×
P / FCF9.1×
Net margin14.6%
FCF margin26.7%
Net debt$34.6B
Enterprise value USD$152.1B
Graham number -58.3%$26.58

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports. The Graham number is Benjamin Graham's rough maximum fair value ($26.58); a green figure means the price is below it.

Profitability & efficiency

Net margin (%)
22.90% 4.80% 21.80% 13.20% -21.20% 15.10% 13.70% 17.80% -18.50% 14.60% 2016201720182019202020212022202320242025
Gross margin (%)
74.50% 70.70% 71.30% 69.10% 72.30% 2016201720182019202020212022202320242025
Operating margin (%)
2016201720182019202020212022202320242025
Return on equity (%)
27.30% 8.50% 34.80% 6.70% -23.80% 19.40% 20.30% 27.20% -54.60% 38.10% 2016201720182019202020212022202320242025
Shares outstanding
1.68B 1.65B 1.64B 1.71B 2.26B 2.25B 2.15B 2.08B 2.03B 2.04B 2016201720182019202020212022202320242025
Net debt ($)
$1.48B $1.55B -$16.0M $33.80B $35.79B $30.39B $29.83B $28.06B $39.09B $34.62B 2016201720182019202020212022202320242025
Share buybacks ($)
2016201720182019202020212022202320242025
Return on assets (%)
13.20% 3.00% 14.10% 2.60% -7.60% 6.40% 6.50% 8.40% -9.70% 7.80% 2016201720182019202020212022202320242025
Free cash flow margin (%)
9.50% 20.30% 27.10% 28.20% 31.30% 32.80% 25.90% 28.10% 28.90% 26.70% 2016201720182019202020212022202320242025
Debt / equity (×)
0.35× 0.59× 0.49× 0.89× 1.33× 1.23× 1.25× 1.34× 3.02× 2.42× 2016201720182019202020212022202320242025
EPS ($)
$2.65 $0.61 $3.01 $2.01 -$3.99 $3.12 $2.95 $3.86 -$4.41 $3.46 2016201720182019202020212022202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

P / E vs its own history

BRISTOL MYERS SQUIBB CO trades at about 18.4× earnings — below its 10-year norm (10-year range 12.7×–102.6×, median 24.6×).

12.7× 102.6×

Shaded band = 10-year range (12.7×–102.6×); dot = today's 18.4×.

Historical P/E = month-end price near each fiscal year-end ÷ that year's EPS. A read on whether the stock is cheap or dear relative to how it has typically been valued — not a forecast.

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Gross margin72.3%69.1%71.3%70.7%74.5%
Net margin14.6%-18.5%17.8%13.7%15.1%-21.2%13.2%21.8%4.8%22.9%
FCF margin26.7%28.9%28.1%25.9%32.8%31.3%28.2%27.1%20.3%9.5%
Return on assets7.8%-9.7%8.4%6.5%6.4%-7.6%2.6%14.1%3.0%13.2%
Return on equity38.1%-54.6%27.2%20.3%19.4%-23.8%6.7%34.8%8.5%27.3%
Debt / equity2.42×3.02×1.34×1.25×1.23×1.33×0.89×0.49×0.59×0.35×
Current ratio1.261.251.431.251.521.581.601.661.551.55

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.